A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas(Integrated DNA Technologies (United States)), Mark A. Behlke(Integrated DNA Technologies (United States))
Cited by 796
Related Papers
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
|Nucleic Acids Research|2015|458
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
|New England Journal of Medicine|2025|272
A miR-19 regulon that controls NF-κB signaling
|Nucleic Acids Research|2012|174
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
|Nature Communications|2021|171